IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aquilo Capital Management, LLC

Q1 2019 Holdings

Filed 2019-05-15 | 14 holdings | $19.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$18.0M982,45593.3%
Cytomx Therapeutics Inc(CTMX)COM23284F105$1.1M101,7675.7%
Ishares TR(IBB)PutNASDAQ BIOTECH464287556$55.9K500,0000.3%
Spdr Series Trust(XBI)PutS&P BIOTECH78464A870$45.3K500,0000.2%
Merus N VCOMN5749R100$22.0K1,491,4970.1%
Uniqure NV(QURE)SHSN90064101$21.7K364,5960.1%
Spero Therapeutics Inc(SPRO)COM84833T103$13.5K1,054,3560.1%
Fate Therapeutics Inc(FATE)COM31189P102$12.2K697,0960.1%
Synlogic IncCOM87166L100$10.6K1,397,0160.1%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$9.7K951,5270.1%
Proqr Thrapeutics N VSHS EURON71542909$6.8K486,6980.0%
Pieris Pharmaceuticals IncCOM720795103$4.1K1,210,8370.0%
Galapagos NV(GLPG)SPON ADR36315X101$2.6K21,8400.0%
Blueprint Medicines Corp(2L9)COM09627Y109$2.5K30,6180.0%